NKTR - Company ID 0000906709
The table below shows NEKTAR THERAPEUTICS's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $15.12M | $44.25M | $35.28M | $88.23M | $25.22M | $198.96M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | $0.00 | $1.21M | $5.98M | $22.49M | $38.89M |
| Inventory | $0.00 | $0.00 | $16.10M | $19.20M | $15.80M | $15.29M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $266.27M |
| $261.29M |
| $330.70M |
| $545.97M |
| $795.58M |
| $1.14B |
| Property, plant & equipment | $2.06M | $3.41M | $18.86M | $32.45M | $60.51M | $59.66M |
| Goodwill | - | $0.00 | $0.00 | $76.50M | $76.50M | $76.50M |
| Total assets | $280.41M | $303.85M | $398.03M | $710.60M | $1.12B | $1.54B |
| Accounts payable | $10.77M | $11.56M | $9.85M | $12.98M | $9.75M | $22.14M |
| Total current liabilities | $53.54M | $61.40M | $51.27M | $68.20M | $85.20M | $115.78M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $190.57M | $243.11M | $267.05M | $343.96M | $437.68M | $461.47M |
| Retained earnings | -$3.76B | -$3.60B | -$3.48B | -$3.20B | -$2.83B | -$2.31B |
| Total equity | $89.83M | $60.74M | $130.99M | $366.64M | $679.51M | $1.08B |